Records containing: Recurrent Adult Brain Tumor

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2025-07-24
A Phase II Open Label, Two-armed Translational Study of Nivolumab in Combination With Bevacizumab for Recurrent Glioblastoma
CLINICAL_TRIALS study record update · 2025-03-20
Pilot Study of High-Dose Chemotherapy With Busulfan, Melphalan, and Topotecan Followed by Autologous Hematopoietic Stem Cell Transplant in Advanced Stage and Recurrent Tumors
CLINICAL_TRIALS study record update · 2025-02-17
A Prospective Phase II Trial of NovoTTF-100A With Bevacizumab (Avastin) in Patients With Recurrent Glioblastoma
CLINICAL_TRIALS study record update · 2024-02-22
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma: Study Protocol for An International Multicenter Prospective Cohort Study (ENCRAM 2301)
CLINICAL_TRIALS study record update · 2021-09-29
A Phase I Study of Cytosine Deaminase-Expressing Neural Stem Cells in Combination With Oral 5-Fluorocytosine and Leucovorin for the Treatment of Recurrent High-Grade Gliomas
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2021-01-22
Phase II Trial of Bevacizumab in Patients With Recurrent or Progressive Meningiomas
CLINICAL_TRIALS study record update · 2020-12-10
Proton Radiation for Low Grade Gliomas
CLINICAL_TRIALS study record update · 2020-11-04
A Phase II Clinical Trial Evaluating Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen for the Treatment of Low-grade Glioma
CLINICAL_TRIALS study record update · 2020-03-17
Randomized Phase II Trial of Concurrent Bevacizumab and Re-Irradiation Versus Bevacizumab Alone as Treatment for Recurrent Glioblastoma
CLINICAL_TRIALS study record update · 2019-09-09
Phase I Study of Alisertib With Concurrent Fractionated Stereotactic Radiation Treatment for Recurrent High Grade Gliomas
CLINICAL_TRIALS study record update · 2019-09-06
Phase 1-2 18F-FPPRGD2 PET/CT or PET/MRI Imaging of αvβ3 Integrins Expression as a Biomarker of Angiogenesis
CLINICAL_TRIALS study record update · 2019-06-12
A Phase II Randomized Trial Comparing the Efficacy of Heat Shock Protein-Peptide Complex-96 (HSPPC-96) (NSC #725085, ALLIANCE IND # 15380) Vaccine Given With Bevacizumab Versus Bevacizumab Alone in the Treatment of Surgically Resectable Recurrent Glioblastoma Multiforme (GBM)
CLINICAL_TRIALS study record update · 2018-08-01
A Phase I Single Arm Open Label Study of Erlotinib and 13-cis-Retinoic Acid (CRA) in Patients With Recurrent Malignant Gliomas
CLINICAL_TRIALS study record update · 2018-07-31
A Phase 2 Comparative Study of 5-Aminolevulinic Acid (5-ALA) and Intraoperative MRI (iMRI) to Enhance Completeness of Resection of Glioblastoma
CLINICAL_TRIALS study record update · 2018-07-03
Yoga and Brain Cancer: A Feasibility Study
CLINICAL_TRIALS study record update · 2018-07-02
Phase I/II Studies of BAY 43-9006 (Sorafenib) in Combination With OSI-774 (Erlotinib), R115777 (Tipifarnib) or CCI-779 (Temsirolimus) in Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
CLINICAL_TRIALS study record update · 2018-07-02
Intracerebral Convection Enhanced Delivery of Carboplatin for Treatment of Recurrent High-grade Gliomas
CLINICAL_TRIALS study record update · 2018-04-17
BAFETINIB-P1-GBM-01: A Pilot Study Using Intracerebral Microdialysis to Determine the Neuropharmacokinetics of Bafetinib in Patients With Recurrent Brain Tumors
CLINICAL_TRIALS study record update · 2017-11-09
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
CLINICAL_TRIALS study record update · 2017-08-16
A Biomarker and Phase II Study of GDC-0449 in Patients With Recurrent Glioblastoma Multiforme
CLINICAL_TRIALS study record update · 2017-08-08
Phase II Study of TKI258 (Dovitinib) in Patients With Recurrent or Progressive Glioblastoma Who Have Progressed With or Without Anti-Angiogenic Therapy (Including Anti-VEGF Therapy)
CLINICAL_TRIALS study record update · 2017-07-13
A Phase I/II Trial of OSI-774 in Patients With Recurrent Malignant Gliomas and Malignant Gliomas Post Radiation Therapy
CLINICAL_TRIALS study record update · 2017-07-12
A Phase 2 Study of R-(-)-Gossypol (Ascenta's AT-101) in Recurrent Glioblastoma Multiforme
CLINICAL_TRIALS study record update · 2017-06-14
Phase II Trial of EMD 121974 for Recurrent Glioblastoma: A Clinical Trial With Tissue Correlates of Response
CLINICAL_TRIALS study record update · 2017-05-15
Phase II Trial of STI571 (NSC 716051) in Patients With Recurrent Meningioma